Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluation
High-throughput chemistry (HTC) and direct-to-biology (D2B) platforms allow for plate-based compound synthesis and biological evaluation of crude mixtures in cellular assays. The rise of these workflows has rapidly accelerated drug-discovery programs in the field of targeted protein degradation (TPD) in recent years by removing a key bottleneck of compound purification. However, the number of chemical transformations amenable to this methodology remain minimal, leading to limitations in the exploration of chemical space using existing library-based approaches. In this work, we expanded the toolbox by synthesising a library of degraders in D2B format. First, reaction conditions are established for performing key medicinal chemistry transformations, including reductive amination, S<sub>N</sub>Ar, palladium-mediated cross-coupling and alkylation, in D2B format. Second, the utility of these alternative reactions is demonstrated by rapidly identifying developable PROTACs for a range of protein targets.
Authors
- Harry J. Shrives
- Jenni Cryan (ORCID: https://orcid.org/0000-0001-8923-6121)
- David Battersby (ORCID: https://orcid.org/0009-0006-8159-9423)
- Rebecca Stevens (ORCID: https://orcid.org/0009-0002-4675-058X)
- Diana Klimaszewska
- Peter Stacey
- John D. Harling (ORCID: https://orcid.org/0000-0003-3602-324X)
- Glenn A. Burley (ORCID: https://orcid.org/0000-0002-4896-113X)
- Afjal H. Miah (ORCID: https://orcid.org/0000-0002-9592-7495)
Institutions
- University of Strathclyde (GB)
- Age UK (GB)
Publication Details
- Journal
- RSC Medicinal Chemistry
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1039/d4md00760c
- Citations
- 17
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 3.97
Funders
- GlaxoSmithKline
- University of Strathclyde
- Society of Chemical Industry
- Royal Commission for the Exhibition of 1851